Evolus Announces Presentations of Phase II and Phase III Data of PrabotulinumtoxinA | Boulder Peptide Symposium

September 15-18, 2025

LIVE, In Person at the St. Julien Hotel in Boulder, Colorado
The only conference focused solely on the pharmaceutical development of peptide therapeutics.
MENU

Evolus Announces Presentations of Phase II and Phase III Data of PrabotulinumtoxinA

Evolus Announces Presentations of Phase II and Phase III Data of PrabotulinumtoxinA
Peptide News from Biotech and Pharma, Raw News October 10, 2017

SANTA BARBARA, CA, USA I October 9, 2017 I Evolus, Inc. (www.Evolus.com) today announced presentations of the data from the Phase II and III ...

Email

support@boulderpeptide.org

s2Member®
loading...